PDF(2229 KB)
Integrated toxicology: an effective solution for explaining the “Toxicity” of traditional Chinese medicine
Huanhua Xu, Wei Zhou, Jianfeng Yi, Boli Zhang, Yue Gao
PDF(2229 KB)
PDF(2229 KB)
Integrated toxicology: an effective solution for explaining the “Toxicity” of traditional Chinese medicine
| [[1]] |
Huang R, Cai Y, Yang L, et al. Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China. Sci Rep. 2021;11(1):8875.
|
| [[2]] |
Ng AWT, Poon SL, Huang MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med. 2017;9(412):eaan6446.
|
| [[3]] |
Gao Y, Li C, Liang AH, et al. Compatibility for toxicity attenuation of toxic traditional Chinese medicine: a review and strategies. Zhongguo Zhong Yao Za Zhi. 2022;47(8):1989-1994.
|
| [[4]] |
Shen P, Sun DZ, Zhou W, et al. Research progress in toxicity prediction of traditional Chinese medicines. Chin J Pharmacovigilance. 2023;20(4):473-479.
|
| [[5]] |
Xu X, Li GM, Sun C, et al. Research progress on water-soluble alkaloids from Fuzi(附子) and their pharmacological effects. Pharmacol Clin Chin Mater. 2021;37(5):213-219.
|
| [[6]] |
Yang X, Xia D, Tian CH, et al. Literature analysis of 508 cases reports of adverse reactions induced by aconiti lateralis radix praeparata. Chin J Pharmacovigilance. 2017;14(10):615-621.
|
| [[7]] |
Xiang Y, Guo AX, Zhang SF, et al. Efficacy analysis of compound Huangdai tablets in the treatment of acute promyelocytic leukemia. Chin J Pract Intern Med. 1999;19(10):611-612.
|
| [[8]] |
Zhu HH, Hu J, Lo-Coco F, et al. The simpler, the better: oral arsenic for acute promyelocytic leukemia. Blood. 2019;134(7):597-605.
|
| [[9]] |
Zhu HH, Wu DP, Jin J, et al. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. J Clin Oncol. 2013;31(33):4215-4221.
|
| [[10]] |
Wang L, Zhou GB, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A. 2008;105(12):4826-4831.
|
| [[11]] |
Zhang X, Chen H, Huang X, et al. Single-cell transcriptomics profiling the compatibility mechanism of As2O3-indigo naturalis formula based on bone marrow stroma cells. Biomed Pharmacother. 2022;151:113182.
|
| [[12]] |
Xu HH, Ma ZC, Shi QL, et al. Synergistic effect and different toxicities of adjuvant components of Realgar-Indigo Naturalis formula. Chin Herb Med. 2018;10(2):137-144.
|
| [[13]] |
Xu HH, Hao FR, Wang MX, et al. Influences of Realgar-Indigo naturalis, a traditional Chinese medicine formula, on the main CYP450 activities in rats using a cocktail method. Evid Based Complement Alternat Med. 2017;2017:2374624.
|
| [[14]] |
Jiang Z, Sun Y, Wu Z, et al. Dissection of scientific compatibility of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia from the perspective of toxicology. J Ethnopharmacol. 2023;317:116895.
|
| [[15]] |
Shi Z, Gao J, Pan J, et al. A systematic review on the safety of Psoraleae Fructus: potential risks, toxic characteristics, underlying mechanisms and detoxification methods. Chin J Nat Med. 2022;20(11):805-813.
|
| [[16]] |
Yang Y, Zhou W, Wang Y, et al. Bavachin induces liver injury and cell apoptosis by targeting Wnt/β-catenin/DRP1 signaling pathway mediated mitochondrial dysfunction. Toxicol Lett. 2023;387:1-13.
|
| [[17]] |
Huang CS, Deng HF, Zhou L, et al. Undesirable ER stress induced by bavachin contributed to follicular atresia in zebrafish ovary. Biomed Pharmacother. 2023;166:115322.
|
| [[18]] |
Shen P, Bai ZJ, Zhou L, et al. A Scd1-mediated metabolic alteration participates in liver responses to low-dose bavachin. J Pharm Anal. 2023;13(7):806-816.
|
/
| 〈 |
|
〉 |
AI Summary
